Trending...
- California: Governor Newsom announces appointments 12.30.2025
- California: Governor Newsom honors fallen CAL FIRE Engineer
- Governor Newsom prepositions emergency resources in Southern California ahead of New Year's Storm
Semi-quantitative measurement of activation of human NFkB p65 in nuclear extracts or cell lysates.
MILPITAS, Calif. - Californer -- Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) represents a family of inducible transcription factors, which regulates many biological processes including immune responses, cell growth, apoptosis etc. This family includes five structurally related members namely NF-κB1 (or p50), NF-κB2 (or p52), RelA (or p65), RelB and c-Rel, which are normally sequestered in the cytoplasm by a family of inhibitory proteins and are inactive.
Upon stimulation, NF-κB proteins form homo- or heterodimers and are transported into the nucleus where they bind to specific DNA sequences of targeted genes and activate transcription. Traditionally, western blot is used to detect the expression of NFkB and electrophoretic mobility shift assay or reporter assays are used to measure the NFkB activity respectively. But some of these methods are time consuming, laborious, and require radioactivity. BioVision's NFkB RelA/p65 Transcription Factor Activity Assay is a 96-well plate based colorimetric assay to measure the activation of human NFkB p65 in nuclear extracts or cell lysates.
More on The Californer
The kit offers easy, rapid, sensitive and non-radioactive way to detect the activation of transcription factors in samples. In this assay, double stranded DNA sequence containing the NFkB p65 consensus binding site is coated on the 96-well plate. Active NFkB p65 in the cell lysate or the nuclear extract binds to the oligonucleotides on the plate. After the addition of RelA/p65 primary antibody that recognizes the NFkB p65-oligonucleotide complex, a HRP-conjugated secondary antibody is added followed by the addition of TMB substrate and a color signal is developed, which is measured at 450 nm.
Storage Conditions: Multiple Temperatures
USAGE: For Research Use Only! Not For Use in Humans
For more information on this Assay Kit Cat# K2093 https://bit.ly/3l2TzNM
Upon stimulation, NF-κB proteins form homo- or heterodimers and are transported into the nucleus where they bind to specific DNA sequences of targeted genes and activate transcription. Traditionally, western blot is used to detect the expression of NFkB and electrophoretic mobility shift assay or reporter assays are used to measure the NFkB activity respectively. But some of these methods are time consuming, laborious, and require radioactivity. BioVision's NFkB RelA/p65 Transcription Factor Activity Assay is a 96-well plate based colorimetric assay to measure the activation of human NFkB p65 in nuclear extracts or cell lysates.
More on The Californer
- 113 Digital Media Announces the Visibility +PR Alignment Package
- Snell & Wilmer Attorney Gregory J. Sonnenberg Named Chair of CRF-OC's Associate Board of Directors
- California: As federal aid stalls, Governor Newsom announces proposed effort to close insurance gaps for LA fire survivors, expands mortgage relief
- Southeast Ventura County YMCA Served Over 34,000 People, Provided $439,797 In Financial Ad in 2025
- BrassTranscripts Expands AI Prompt Library to 104 Templates with Sales and Pricing Calculators
The kit offers easy, rapid, sensitive and non-radioactive way to detect the activation of transcription factors in samples. In this assay, double stranded DNA sequence containing the NFkB p65 consensus binding site is coated on the 96-well plate. Active NFkB p65 in the cell lysate or the nuclear extract binds to the oligonucleotides on the plate. After the addition of RelA/p65 primary antibody that recognizes the NFkB p65-oligonucleotide complex, a HRP-conjugated secondary antibody is added followed by the addition of TMB substrate and a color signal is developed, which is measured at 450 nm.
Storage Conditions: Multiple Temperatures
USAGE: For Research Use Only! Not For Use in Humans
For more information on this Assay Kit Cat# K2093 https://bit.ly/3l2TzNM
Source: BioVision Inc
0 Comments
Latest on The Californer
- Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration
- Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
- Reditus Group Introduces A New Empirical Model for Early-Stage B2B Growth
- CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
- NEXO, the First AI Artist From 2045, Releases Cinematic Music Video for "STACK BAGS"
- GCAC adds InJoy as Efixii NFT Coupon Reseller
- Award Winning Comedian Returns to Diamond Mountain
- IT IS WHAT IT IS by Rodrigo Angel Jimenez-Ortega
- Goatimus Launches Dynamic Context: AI Prompt Engineering Gets Smarter
- Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
- Former San Francisco Top 40 DJ Releases Candid Memoir of Radio's TOP 40-dominant years
- California: Governor Newsom issues proclamation declaring 2026 statewide primary election date
- RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
- California: Governor Newsom issues statement on Trump administration's vaccine schedule endangering the lives of infants and children
- City of Long Beach to Host Compost and Recycling Ambassador Program in English and Spanish this Spring
- American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
- Happy new year! EyeQue Announces Leadership Transition
- Lineus Medical Completes UK Registration for SafeBreak® Vascular
- Boleros de Noche Celebrates '10 Años'